APA (7th ed.) Citation

MM, A., R, N., ZK, O., SS, M., OJ, O., UO, A., . . . 3rd, L. P. D. (2026). GLP-1 receptor agonists in primary care: Readiness, equity, and the risk of a two-tiered obesity treatment landscape. Therapeutic advances in endocrinology and metabolism, 17, 20420188261472587. https://doi.org/10.1177/20420188261472587

Chicago Style (17th ed.) Citation

MM, Ahmed, Nazari R, Othman ZK, Musa SS, Okesanya OJ, Adebayo UO, Branda F, Elmi AH, and Lucero Prisno DE 3rd. "GLP-1 Receptor Agonists in Primary Care: Readiness, Equity, and the Risk of a Two-tiered Obesity Treatment Landscape." Therapeutic Advances in Endocrinology and Metabolism 17 (2026): 20420188261472587. https://doi.org/10.1177/20420188261472587.

MLA (9th ed.) Citation

MM, Ahmed, et al. "GLP-1 Receptor Agonists in Primary Care: Readiness, Equity, and the Risk of a Two-tiered Obesity Treatment Landscape." Therapeutic Advances in Endocrinology and Metabolism, vol. 17, 2026, p. 20420188261472587, https://doi.org/10.1177/20420188261472587.